As global sponsors seek more diverse, efficient and scalable solutions for clinical research, Latin America (LATAM) is emerging as a powerful yet underutilized region — including in ophthalmology. Join Fortrea this World Sight Day for a dynamic webinar exploring how LATAM’s unique healthcare landscape, patient population and site infrastructure can accelerate ophthalmology clinical trials and improve global trial equity.
Attendees will gain strategic insights from leading experts across the region. Tanya Richardson, Fortrea’s Therapeutic Strategy Head for Ophthalmology and Neuroscience, will be joined by renowned LATAM Principal Investigator Dr. Patricio Schlottman, representatives from IDOR (a premier site network and data lake in Brazil) and Fortrea’s Senior Clinical Research Associate Teresa Barros.
Together, the featured speakers will explore:
LATAM’s strategic advantage in a volatile global research environment — highlighting regulatory stability, sponsor interest and the region’s growing role in diverse and inclusive trials
The patient opportunity in LATAM, where public-private healthcare dynamics and IDOR’s data-driven access model are transforming clinical trials into viable care pathways
What makes a site “trial-ready” in ophthalmology, with real-world lessons from Argentina and Brazil
The power of partnership and how CRO-site collaboration is key to unlocking LATAM’s full potential
Furthermore, attendees will get a glimpse into the future of patient identification with real-world applications of AI and electronic medical records technologies — already in use across IDOR’s network.
Whether a sponsor, site or clinical operations leader, this session will equip attendees with actionable strategies to expand trial footprints and improve patient access in ophthalmology.
Register for this webinar to discover how LATAM can help you reach untapped patient populations, accelerate timelines and deliver more inclusive ophthalmology clinical trials.
Attendees will gain insight into:
- Why LATAM is becoming a strategic hotspot for ophthalmology clinical trials amid global volatility
- How patient access models and data lakes like IDOR’s are reshaping recruitment and care pathways
- What makes a site “trial-ready” in LATAM, with lessons from Argentina and Brazil
- How CRO-site partnerships and emerging tech like AI are driving smarter, faster patient identification
This webinar will appeal to:
- Clinical Research Directors and Medical Directors in Ophthalmology
- Biotech and pharma companies focused on ophthalmic innovation
- Clinical Operations and R&D Leaders exploring LATAM expansion
- Biopharmaceutical Developers
- Research and Development Directors
- Clinical Development Leads
- Biomarker Discovery/Development Scientists
- Clinical Biomarker Leads
- Head of Personalized Medicine
- Translational Biomarker Scientists
